Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: In the time since the original proposal to move healthwriting companies from the blue blank to the orange blank, there have been several incremental updates to the blue blank by the NAIC Blanks Working Group to integrate portions of the orange blank into the blue blank. Meanwhile, the NAIC RBC Working Group has issued their proposal to change the health test for comment and appear to be moving forward with the proposal to revise the health test. This would obligate companies that write predominantly health business onto the orange blank rather than the blue blank, which they have historically used for reporting. Discover background of the revised health test, the incremental updates to the blue blank that have been implemented recently, additional incremental updates proposed for upcoming blue blanks, and the current status of the Health RBC Working Group proposal to revise the health test. Hear observations about companies that have opted to 'take the plunge' and move to the orange blank ahead of the revised health test as well as companies that have opted to remain on the blue blank and incrementally update as new requirements are integrated into the Blue blank. By attending the session, you will be able to: • Understand the context of the initiative to revise the NAIC health test. • Summarize the recent changes to the blue blank implemented by the Blanks Working Group that integrate portions of the orange blank into the blue blank. • Summarize the upcoming proposed changes to the blue blank by the Blanks Working Group that integrate additional portions of the orange blank into the blue blank. • Summarize the current status of the Health RBC Working Group proposal to revise the health test. • Provide industry perspective on companies that have opted to move to the orange blank ahead of the revised health test and companies that have opted to remain on the blue blank until the NAIC requires it.

Description: The topics of ESG (Environmental, Social & Corporate Governance) and sustainability are an increasing area of focus for insurance companies, and thus actuaries. This webcast provides a primer on these topics along with considerations for US valuation actuaries and their evolution in European insurance markets.

Description: Learn how modernization of data, models, and technology are influencing workflows. This webcast will address how workflows are changing in response to new regulatory requirements and the impacts the changes have on modeling and end-to-end future state operating models. Industry leading actuaries will discuss: How team collaboration can increase quality and speed of reporting to internal and external stakeholders How to strengthen controls and compliance frameworks across finance and actuarial departments How to modernize actuarial input/output for strategic analysis and insights How to attract and retain top talent by improving opportunities for actuaries There will also be dedicated time to ask questions of those who have made the transition.

Description: Learn from panelists from different companies as they come together to discuss their experiences.

Description: Actuarial projects have become more intricate, involving external resources and requests beyond the actuarial team's purview. Whether a task appears minor or exceptionally complex, adept project and change management play a pivotal role in successful execution. In this session, we explore practical strategies for tailoring implementation management approaches.

Description: The Smaller Insurance Company/Chief Actuary Forum presents a unique format for focusing on issues faced by actuaries in leadership positions or actuaries supporting the Chief Actuary. By discussing critical issues with your peers, you will leave with ideas to incorporate in your business environment. The Forum will feature presentations to introduce several of the discussion topics, followed by an opportunity to break into smaller discussion groups and rotate among topics.

Description: This debate-style presentation focuses on metrics used to measure and manage insurance companies. Changes in accounting bases (LDTI, IFRS17, etc.) challenge historic metrics to be adjusted or replaced to accommodate new regimes. The long-duration nature of revenue recognition and profit emergence is unique to the insurance industry, and there is no debating the importance of accounting regimes to facilitate earnings recognition and comparability. However, insurers face challenges from the inherent mismatch between capital measures and accounting profits. This mismatch creates competing interest when it comes to both management decisions and executive compensation. To provide guidance, experts offer their unique perspectives and opinions to a debate of emerging best practices in accounting KPIs, cash-based metrics, and executive incentives. The discussion will be guided by probing questions, such as: - What challenges are faced by external users of financial statements? - Accounting changes did not impact business economics, so why discuss metrics? - What are examples of historic and emerging accounting and cash-based metrics? - How can insurers implement best practices in financial reporting? At the conclusion of the session, attendees will have an improved appreciation for actuarial valuation, specifically, the critical role that our interpretation of results plays in the broader financial system.

Description: Over the last few years, a significant amount of US annuity and pension business has been reinsured with offshore companies, both affiliated and non-affiliated. Hear experts discuss different reserve and capital regimes between the US and offshore jurisdictions, as well as US regulator concerns and responses. The attendees will learn the reasons companies use offshore reinsurance, and improve their understanding of the discussion of proposals to increase US regulator and consumer comfort with companies outside of US jurisdiction.

Description: The Smaller Insurance Company Section Buzz Groups at the Valuation Actuary Meetings and the SOA Annual Meetings have always generated great discussions, ideas, and opportunities to hear about topics that affect the actuarial work of small companies. Join us for the Smaller Insurance Company Section Buzz Group to discuss the issues affecting Smaller (and larger) Insurance Company actuaries during these emerging changes. Bring your thoughts, opinions, ideas, and participation to discuss our special concerns.